4180018-2026 - AQ 2023/491 - Oncology and Immunomodulatory Medications
About This Opportunity
TranslatedThis tender, identified by reference numbers 4180018-2026 and AQ 2023/491, is for the acquisition of medications used in oncology and for immunomodulatory purposes. The scope of the procurement covers a range of pharmaceutical products essential for treating cancer patients and individuals requiring modulation of their immune system. The procuring entity, likely a healthcare institution or public health service, seeks to secure a reliable supply of these critical medicines. The tender will specify the exact list of medications required, including their dosage forms, strengths, and quantities. Bidders are expected to be authorized pharmaceutical suppliers capable of meeting stringent quality standards and delivery schedules. The evaluation criteria will likely focus on the proposed price, quality of the offered products, reliability of supply, and compliance with regulatory requirements for pharmaceutical distribution. This procurement is vital for ensuring that patients have access to necessary treatments for oncological conditions and immune-related disorders, thereby supporting public health services and patient care within the relevant jurisdiction.
This is a supplies contract in the health and medical services, transport and logistics and trade and industry sectors, with a focus on Pharmaceuticals and Logistics. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 105.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender, identified by reference 4180018-2026 and AQ 2023/491, is an open procurement opportunity issued by a contracting authority within Portugal. The subject of this procurement is the supply of oncological and immunomodulatory medications. This signifies a critical requirement for a range of pharmaceutical products essential for treating cancer and conditions where the immune system needs to be modulated.
The contracting authority, operating within the public sector of Portugal, is seeking to establish framework agreements or direct purchase contracts for these specialized medicines. Companies with proven experience in the pharmaceutical supply chain, particularly in oncology and immunology, are invited to participate. Typical requirements for such tenders often include demonstrating the ability to meet stringent quality standards, ensuring a consistent and reliable supply chain, adherence to Good Distribution Practices (GDP), and providing competitive pricing. Bidders will likely need to present comprehensive product portfolios, detailed technical specifications, and evidence of regulatory compliance. Furthermore, considerations such as packaging, delivery logistics, and post-supply support may also be evaluated. This tender represents a significant opportunity for pharmaceutical manufacturers and distributors to engage with the Portuguese public healthcare system.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 13, 2026. Last refreshed 7 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Arco Ribeirinho, E.P.E.
Unidade Local de Saúde do Arco Ribeirinho, E.P.E. has issued 554 procurement notices on BidsFactory, including 2 currently open and 548 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What is the estimated budget?
The estimated contract value is Up to €105. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to BDR PHARMA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Arco Ribeirinho, E.P.E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.